Dynatronics (DYNT) Receives Media Impact Score of 0.08
News stories about Dynatronics (NASDAQ:DYNT) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Dynatronics earned a daily sentiment score of 0.08 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 45.39872448679 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the media headlines that may have effected Accern Sentiment Analysis’s scoring:
- Blog Exposure – Dynatronics Signs Distribution Agreement with Orthopedic Outfitters (finance.yahoo.com)
- Dynatronics (DYNT) Upgraded to “Buy” at Zacks Investment Research (americanbankingnews.com)
- Dynatronics (DYNT) Downgraded by Zacks Investment Research to “Hold” (americanbankingnews.com)
- Dynatronics Announces Distribution Agreement with Orthopedic Outfitters (finance.yahoo.com)
- Stuart Essig Acquires 27,455 Shares of Dynatronics Co. (DYNT) Stock (americanbankingnews.com)
Separately, Zacks Investment Research downgraded shares of Dynatronics from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th.
Dynatronics (NASDAQ:DYNT) last posted its quarterly earnings results on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.08. The business had revenue of $12.80 million during the quarter. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. analysts predict that Dynatronics will post -0.09 earnings per share for the current year.
In related news, Director Brian Larkin purchased 40,000 shares of Dynatronics stock in a transaction that occurred on Thursday, November 30th. The shares were bought at an average price of $2.50 per share, for a total transaction of $100,000.00. Following the completion of the transaction, the director now directly owns 80,276 shares of the company’s stock, valued at $200,690. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Ventures 1 Lp Provco purchased 300,000 shares of Dynatronics stock in a transaction that occurred on Thursday, November 30th. The shares were bought at an average price of $2.50 per share, for a total transaction of $750,000.00. Following the transaction, the insider now directly owns 586,944 shares of the company’s stock, valued at $1,467,360. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 369,015 shares of company stock valued at $930,372. Insiders own 51.80% of the company’s stock.
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.